Michael Gelband’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Michael Gelband’s Portfolio FLXN Stock Details FLXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-114,564	Closed	-$699K	–	2810
2021 Q3	$699K	Buy	114,564 +87,417	+322%	+$545K	0.01%	1209
2021 Q2	$223K	Sell	27,147 -15,081	-36%	-$128K	﹤0.01%	1915
2021 Q1	$378K	Buy	42,228 +32,136	+318%	+$368K	0.01%	1529
2020 Q4	$116K	Buy	+10,092	New	+$117K	﹤0.01%	1816
2020 Q1	–	Sell	-12,707	Closed	-$263K	–	1838
2019 Q4	$263K	Sell	12,707 -1,389	-10%	-$23.4K	﹤0.01%	1216
2019 Q3	$193K	Buy	+14,096	New	+$167K	0.01%	1134

Michael Gelband's FLXN Position: Q4 2021 in Review

Michael Gelband sold out of Flexion Therapeutics, Inc. (FLXN) in Q4 2021, closing a stake of 114,564 shares — an estimated $699K sold.

Michael Gelband first reported a position in FLXN in Q3 2019 and held it in 6 quarters. The position peaked at $699K in Q3 2021. 1 fund tracked by Wall St. Rank holds FLXN as of Q4 2021.

Michael Gelband reported no remaining Flexion Therapeutics, Inc. position as of Q4 2021 after selling out during the quarter.
Michael Gelband sold 114,564 Flexion Therapeutics, Inc. shares in Q4 2021, an estimated $699K.
Michael Gelband first reported a position in Flexion Therapeutics, Inc. in Q3 2019 and held it in 6 quarters.
Michael Gelband's Flexion Therapeutics, Inc. position peaked at $699K in Q3 2021.
1 fund tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q4 2021.

Based on ExodusPoint Capital Management's 13F filing for Q4 2021, filed 11 Feb 2022.